Basilea Pharmaceutica has obtained FDA orphan drug status to isavuconazole, an investigational intravenous and oral broad-spectrum antifungal, for the treatment of invasive aspergillosis. Isavuconazole is being investigated in phase 3 ...
Advanced Biological Laboratories (ABL) has received CE Mark approval to market its patient monitoring application TherapyEdge in Europe. TherapyEdge helps to not only capture but also to integrate all patient data and particular decision ...
Tags: CE Mark, Monitoring Application
Drug discovery and early drug development company Trino Therapeutics has received more than €9m ($12m) funding from investors, including Fountain Healthcare Partners and founding investor, the Wellcome Trust, to advance the development ...
Tags: Trino, Colitis Drug
The European Commission has approved Gilead Sciences' Stribild for marketing as the single tablet regimen for HIV-1 treatment in all 27 countries of the European Union. Four of the Gilead's compounds elvitegravir 150mg, cobicistat 150mg, ...
Integrated biopharmaceutical company ThromboGenics has announced the launch of Jetrea in Denmark and Sweden by Alcon, a division of Novartis. Alcon expects to roll out the European Commission approved Jetrea, which is indicated for the ...
AstraZeneca has agreed to acquire Omthera Pharmaceuticals along with novel dyslipidemia treatment in a deal, which has a total potential cost of nearly $443m. As per the deal, AstraZeneca will acquire Omthera for $12.70 per share, or ...
Tags: Pharmaceuticals, Astrazeneca
Boston Scientific has received CE Mark approval for use of the GUIDE DBS System, a deep brain stimulation (DBS) visual simulation system. GUIDE DBS offers clinicians with 3D visualization information that simulates stimulation output, ...
Tags: CE Mark, DBS System
GlucoMen, a brand of A.Menarini Diagnostics, has introduced a new smartphone app GlucoLog Lite to maintain a complete record of patients' blood glucose history without paper logbook. The GlucoLog Lite app records the results of all the ...
Tags: GlucoMen, Blood Glucose History
Singapore-based medical devices manufacturer Biosensors International has completed the acquisition of substantially all assets of Spectrum Dynamics, a provider of avanced functional assessment technologies such as those used to evaluate ...
Sangamo BioSciences has received a $6.4m strategic partnership grant from the California Institute for Regenerative Medicine (CIRM) for the development of ZFP Therapeutic for Beta-thalassemia. The application of its zinc finger nuclease ...
Tags: Sangamo, ZFG Therapeutic
Mitsubishi Tanabe Pharma is seeking manufacturing and marketing approval of TA-7284 (generic name: canagliflozin) in Japan. The company filed a new drug application to the Ministry of Health, Labor and Welfare in Japan for TA-7284 to ...
Tags: Mitsubishi, canagliflozin
Astellas Pharma and Medivation have announced the submission of application for marketing approval of enzalutamide in Japan for the treatment of prostate cancer. The application was filed by Astellas with the Ministry of Health, Labour ...
Tags: Astellas, Marketing Application
Fresenius Kabi USA has commenced a voluntary recall of one lot of Magnesium Sulfate Injection, USP, as part of its precautionary measure. After a regular company inspection of retained product samples, the recall was announced due to the ...
Tags: Fresenius Kabi, recalled product
Global healthcare company Novo Nordisk has announced plans to launch its obesity treatment drug, liraglutide, in the US by the end of 2014. Novo chief scientific officer Mads Thomsen was quoted by health24.com as saying that liraglutide ...
Tags: Obesity Drug, Medicine
Swiss agrochemicals company Syngenta has unveiled CLARIVA, a seed treatment nematicide based on the Pasteuria technology. CLARIVA comprises naturally occurring soil bacteria with a direct mode of action on nematodes, microscopic ...